A PHASE II TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) CONCOMITANT WITH RADIOSURGERY FOR THE TREATMENT OF RECURRENT, BEVACIZUMAB-NAIVE GLIOBLASTOMA

被引：0
|
作者：
Harat, Maciej [1 ]
Blok, Maciej [2 ]
Adamczak-Sobczak, Magda [2 ]
Szymanski, Pawel [2 ]
Miechowicz, Iza [3 ]
Malkowski, Bogdan [1 ]
机构：
[1] Nicolaus Copernicus Univ, Coll Med, Bydgoszcz, Poland
[2] Prof Franciszek Lukaszczyk Oncol Ctr, Bydgoszcz, Poland
[3] Poznan Univ Med Sci, Poznan, Poland
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CTNI-46
引用
收藏
页码：52 / 53
页数：3
相关论文
共 50 条
  • [41] Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series
    Ansstas, George
    Tran, David D.
    CASE REPORTS IN NEUROLOGY, 2016, 8 (01): : 1 - 9
  • [42] Phase II study of verubulin (MPC-6827) for the treatment of subjects with recurrent glioblastoma naive to treatment with bevacizumab.
    Kim, L. J.
    Chamberlain, M. C.
    Zhu, J.
    Raizer, J. J.
    Grimm, S. A.
    Phuphanich, S.
    Fadul, C. E.
    Rosenfeld, S.
    Balch, A. H.
    Pope, C. C.
    Brulotte, M.
    Beelen, A. A. P.
    Recht, L. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] A PHASE II STUDY OF TUMOR TREATING FIELDS IN COMBINATION WITH BEVACIZUMAB AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED, UNRESECTABLE GLIOBLASTOMA
    Sumrall, Ashley
    Haggstrom, Daniel
    Burri, Stuart
    Symanowski, James
    NEURO-ONCOLOGY, 2017, 19 : 16 - 16
  • [44] Radiosurgery Followed by Tumor Treating Fields (TTFields) for Brain Metastases (1-10) from NSCLC in the Phase 3 METIS Trial
    Mehta, M.
    Gondi, V.
    Ahluwalia, M.
    Brown, P.
    Weinberg, U.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S664 - S664
  • [45] GENOMIC ANALYSIS OF RESPONDERS OF PHASE II TRIAL OF TEMOZOLOMIDE AND TRC-102 (BASE EXCISION REPAIR INHIBITOR) IN BEVACIZUMAB-NAIVE GLIOBLASTOMA AT FIRST RECURRENCE
    Ahluwalia, Manmeet
    Dhruv, Harshil
    Fallah, Jaleh
    Berens, Michael
    Drappatz, Jan
    Ye, Xiaobu
    Lesser, Glenn
    Cloughesy, Timothy
    Walbert, Tobias
    Holdhoff, Matthias
    Peereboom, David
    Nabors, Louis
    Wen, Patrick
    Grossman, Stuart
    Rogers, Lisa
    NEURO-ONCOLOGY, 2019, 21 : 23 - 23
  • [46] A PHASE 2 STUDY OF TUMOR TREATING FIELDS AND BEVACIZUMAB IN RECURRENT OR PROGRESSIVE MENINGIOMA
    Kumthekar, Priya
    Kruser, Timothy
    Sachdev, Sean
    Raizer, Jeffrey
    Grimm, Sean
    Dixit, Karan
    NEURO-ONCOLOGY, 2017, 19 : 4 - 4
  • [47] Phase 3 TRIDENT study (EF-32): Tumor treating fields (TTFields; 200 kHz) concomitant with chemoradiation, and maintenance TTFields therapy/temozolomide in newly diagnosed glioblastoma
    Shi, Wenyin
    Roberge, David
    Kleinberg, Lawrence
    Jeyapalan, Suriya A.
    Goldlust, Samuel Aaron
    Nagpal, Seema
    Lustgarten, Leonardo
    Combs, Stephanie E.
    Nishikawa, Ryo
    Reardon, David A.
    Grossman, Rachel
    Glas, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] PHASE I TRIAL OF DOSE ESCALATED RADIOSURGERY PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT/PROGRESSIVE GLIOBLASTOMA
    Abbassy, Mahmoud
    Missios, Symeon
    Brewer, Cathy
    Peereboom, David
    Ahluwalia, Manmeet
    Neyman, Gennady
    Chao, Samuel
    Suh, John
    Barnett, Gene
    Vogelbaum, Michael
    NEURO-ONCOLOGY, 2014, 16
  • [49] A PHASE II, SINGLE ARM STUDY OF OPTUNE® IN BEVACIZUMAB-NAIVE SUBJECTS WITH RECURRENT WHO GRADE III MALIGNANT GLIOMA
    O'Connell, Daniel
    Carrillo, Jose
    Kong, Xiao-Tang
    Fu, Beverly
    Bota, Daniela
    NEURO-ONCOLOGY, 2016, 18 : 11 - 11
  • [50] Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma
    Abbassy, Mahmoud
    Missios, Symeon
    Barnett, Gene H.
    Brewer, Cathy
    Peereboom, David M.
    Ahluwalia, Manmeet
    Neyman, Gennady
    Chao, Samuel T.
    Suh, John H.
    Vogelbaum, Michael A.
    NEUROSURGERY, 2018, 83 (03) : 385 - 392
12345